TBL2 methylation is associated with hyper-low-density lipoprotein cholesterolemia: a case-control study

Background HMGCR, SCAP, SREBF1, SREBF2 and TBL2 are well-known genes that are involved in the process of lipid metabolism. However, it is not known whether epigenetic changes of these genes are associated with lipid metabolism. In this study, the methylation levels of the HMGCR, SCAP, SREBF1, SREBF2 and TBL2 genes were analyzed between samples from a hyper-low-density lipoprotein cholesterolemia (hyper-LDL) group and a control group to examine the association between the methylation levels of these genes and the risk of hyper-LDL. Methods In this study, a case-control approach was used to explore the association between DNA methylation and hyper-LDL. The DNA methylation levels of HMGCR, SCAP, SREBF1, SREBF2 and TBL2 genes and 231 CpG sites in the promoter regions of these genes were measured in 98 hyper-LDL participants and 89 participants without hypo-LDL. Results Compared with participants without hyper-LDL, patients with hyper-LDL TBL2 gene had lower methylation levels (11.93 vs. 12.02, P = 0.004). The methylation haplotypes with significant abundance in the TBL2 gene are tcttttttttt ( P = 0.034), ctttttttcct ( P = 0.025), ctctttctttt ( P = 0.040), ccttttttttt ( P = 0.028), and tctttttttttttttt. Conclusion The study demonstrates that participants with hyper-LDL have lower methylation of TBL2 . The results suggest that DNA methylation of TBL2 can decrease the risk for hyper-LDL in humans.